Phase 3 Obstructive Sleep apnoea Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
ObesityOverweightObstructive Sleep apnoea
Novo Nordisk A/S300 enrolled80 locationsNCT07571005
Recruiting
Phase 3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
ObesityOverweightObstructive Sleep apnoea
Novo Nordisk A/S300 enrolled91 locationsNCT07571109
Terminated
Phase 3Phase 4
Montelukast for mild OSA in children
Mild obstructive sleep apnoea (OSA) in children
School of Women's and Children's Health, University of New South Wales40 enrolled1 locationACTRN12607000245493
Recruiting
Phase 3
Obstructive Sleep Apnoea and Cardiovascular Disease
Obstructive Sleep Apnoea (OSA)
NHMRC20 enrolled1 locationACTRN12605000271606